Oral iron therapy for pediatric iron deficiency anemia uses elemental iron dosed by body weight at about 3–6 mg per kilogram per day, usually split into two doses. Splitting the dose helps with tolerability and absorption because iron absorption can be limited by high daily amounts, and dividing it reduces GI side effects like nausea, constipation, and upset stomach. For best results, take the iron with a source of vitamin C to boost absorption, and try to avoid taking it with calcium-containing foods or antacids around the dosing time, since calcium can hinder iron absorption. This dosing range provides enough iron to replenish stores efficiently while keeping side effects manageable; clinicians tailor within this range based on severity and response, and therapy typically continues for about three months after hemoglobin normalizes to rebuild iron stores, with follow-up labs to confirm improvement.

Assessing cerebellar coordination in a young child is best done with the finger-to-nose test because it directly probes the precise, smooth, coordinated aiming movements that the cerebellum controls. In this task, the child repeatedly reaches from their nose to a target (the examiner’s finger) and back, and a normal result shows accurate, fluid motion. If cerebellar function is impaired, you’ll often see dysmetria (overshooting or undershooting the target), an intention tremor, or a breakdown of smooth movement. These signs reflect the cerebellum’s role in calibrating movement and correcting errors in real time. The other tests tap different systems: a quadriceps reflex assesses the spinal reflex arc and peripheral nerve/muscle function; two-point discrimination tests tactile discrimination and dorsal column–medial lemniscus pathways; and following directions measures language, attention, and higher cognitive skills rather than cerebellar coordination. Therefore, finger-to-nose is the most direct way to evaluate cerebellar function in a young child.

By around one year, language development typically includes saying one or two meaningful words and responding to their name. This shows the transition from initial babbling to first expressive words, while also demonstrating receptive language by recognizing their own name, a key social-communication cue. The other scenarios describe skills that usually appear later: having several words and pointing to body parts develops in the second year or later; babbling without responding to name fits earlier infancy; and using complete sentences is something expected well after the first year.

High-dose amoxicillin is the best first-line option for uncomplicated acute otitis media in a healthy child aged 2–12 because it reliably targets the common ear pathogens, especially Streptococcus pneumoniae, and the higher dose ensures sufficient drug reaches the middle ear even when some strains show reduced penicillin sensitivity. This approach uses a narrow, effective antibiotic with a favorable safety and cost profile, maximizing cure rates while minimizing broader-spectrum overuse. Azithromycin is avoided as the first choice because pneumococcus resistance is higher and middle-ear penetration is not as reliable, reducing its effectiveness in AOM. Amoxicillin-clavulanate broadens coverage to beta-lactamase–producing organisms, but it brings more side effects and cost, so it’s typically reserved for specific circumstances such as treatment failure on amoxicillin, recent antibiotics, or particular risk factors. Cefdinir can be an alternative if a penicillin allergy or intolerance is present, but it isn’t preferred in uncomplicated cases due to similar efficacy with potentially more GI effects and higher cost. Recommended dosing for the first-line option is about 80–90 mg/kg/day of amoxicillin, divided twice daily, for 5–7 days depending on age and severity.